1. Cancer Research UK. Bladder cancer statistics. [cited 2021 April 1]; https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer#heading-Zero. Accessed 26 Aug 2021.
2. Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95.
3. Urology Care Foundation. Non-muscle Invasive Bladder Cancer. [cited 2021 August 26]; https://www.urologyhealth.org/urology-a-z/n/non-muscle-invasive-bladder-cancer. Accessed 26 Aug 2021.
4. Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer. 2013;108(7):1534–40.
5. Babaian KN, Adams PG, McClure C, Tompkins B, McMurray M. Bacillus Calmette-Guérin immunotherapy for bladder cancer overview of BCG immunotherapy. 2020 [updated 2020; cited 2021 September 20]; https://emedicine.medscape.com/article/1950803-overview. Accessed 26 Aug 2021.